Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FYSIOTERAPIEN FÆRCHHUSET ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   6.2% 3.9% 5.6% 5.3% 7.6% 6.6% 16.0% 15.8%   Credit score (0-100)   39 52 40 41 31 35 12 12   Credit rating   BBB BBB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,158 1,452 1,455 1,307 1,097 989 0.0 0.0   EBITDA   -4.6 145 -11.2 20.2 124 5.5 0.0 0.0   EBIT   -18.9 108 -76.7 -44.6 69.2 -49.3 0.0 0.0   Pre-tax profit (PTP)   -14.7 102.7 -85.6 -51.0 66.5 -55.0 0.0 0.0   Net earnings   -12.3 79.5 -67.8 -40.4 50.1 -42.9 0.0 0.0   Pre-tax profit without non-rec. items   -14.7 103 -85.6 -51.0 66.5 -55.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   32.8 254 204 139 83.9 29.1 0.0 0.0   Shareholders equity total   126 206 138 97.5 148 105 -28.3 -28.3   Interest-bearing liabilities   0.0 236 189 139 151 97.4 28.3 28.3   Balance sheet total (assets)   426 755 796 549 385 322 0.0 0.0   Net Debt   -93.9 63.6 -53.4 120 141 95.2 28.3 28.3     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,158 1,452 1,455 1,307 1,097 989 0.0 0.0   Gross profit growth   -15.8% 25.4% 0.2% -10.2% -16.0% -9.9% -100.0% 0.0%   Employees   4 4 4 4 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   426 755 796 549 385 322 0 0   Balance sheet change%   -0.8% 77.3% 5.4% -31.0% -29.9% -16.3% -100.0% 0.0%   Added value   -4.6 145.5 -11.2 20.2 134.1 5.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -29 183 -116 -130 -110 -110 -29 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.6% 7.4% -5.3% -3.4% 6.3% -5.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.0% 20.3% -8.9% -5.2% 17.0% -12.4% 0.0% 0.0%   ROI %   -6.5% 38.3% -13.9% -7.8% 22.6% -17.5% 0.0% 0.0%   ROE %   -9.3% 47.9% -39.5% -34.3% 40.9% -34.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   29.6% 27.3% 17.3% 17.8% 38.4% 32.5% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,042.1% 43.7% 476.9% 591.1% 113.6% 1,734.6% 0.0% 0.0%   Gearing %   0.0% 114.5% 136.7% 142.1% 102.1% 93.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 14.7% 7.9% 9.7% 8.8% 9.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.2 1.3 1.4 0.9 0.8 0.0 0.0   Current Ratio   1.2 1.5 1.6 1.9 1.3 1.2 0.0 0.0   Cash and cash equivalent   93.9 172.0 242.0 19.0 9.8 2.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   74.9 168.4 208.9 185.1 63.8 50.2 -14.1 -14.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -1 36 -3 5 45 2 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1 36 -3 5 41 2 0 0   EBIT / employee   -5 27 -19 -11 23 -16 0 0   Net earnings / employee   -3 20 -17 -10 17 -14 0 0